Trevi Therapeutics (TRVI)
(Delayed Data from NSDQ)
$2.73 USD
0.00 (0.00%)
Updated May 13, 2024 04:00 PM ET
After-Market: $2.74 +0.01 (0.37%) 5:14 PM ET
3-Hold of 5 3
D Value F Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/8/24 |
---|---|
Current Quarter | -0.11 |
EPS Last Quarter | -0.11 |
Last EPS Surprise | -22.22% |
ABR | 1.20 |
Earnings ESP
|
-4.76% |
---|---|
Current Year | -0.42 |
Next Year | -0.47 |
EPS (TTM) | -0.34 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.11 | -0.11 | -0.42 | -0.47 |
# of Estimates | 4 | 4 | 4 | 4 |
Most Recent Consensus | -0.09 | -0.08 | -0.46 | -0.62 |
High Estimate | -0.09 | -0.08 | -0.32 | -0.33 |
Low Estimate | -0.11 | -0.12 | -0.46 | -0.62 |
Year ago EPS | -0.07 | -0.08 | -0.29 | -0.42 |
Year over Year Growth Est. | -57.14% | -37.50% | -44.83% | -11.90% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 1 |
Up Last 30 Days | 0 | 0 | 0 | 1 |
Up Last 60 Days | 1 | 1 | 1 | 1 |
Down Last 7 Days | 2 | 2 | 3 | 2 |
Down Last 30 Days | 2 | 2 | 3 | 2 |
Down Last 60 Days | 1 | 1 | 3 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.11 | -0.11 | -0.42 | -0.47 |
7 Days Ago | -0.10 | -0.10 | -0.39 | -0.46 |
30 Days Ago | -0.10 | -0.10 | -0.39 | -0.46 |
60 Days Ago | -0.11 | -0.11 | -0.41 | -0.54 |
90 Days Ago | -0.11 | -0.11 | -0.41 | -0.54 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.11 | -0.11 | -0.45 | -0.51 |
Zacks Consensus Estimate | -0.11 | -0.11 | -0.42 | -0.47 |
Earnings ESP | -4.76% | -4.76% | -7.63% | -9.68% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.11 | -0.08 | -0.08 | -0.07 | NA |
Estimate | -0.09 | -0.10 | -0.09 | -0.09 | NA |
Difference | -0.02 | 0.02 | 0.01 | 0.02 | 0.01 |
Surprise | -22.22% | 20.00% | 11.11% | 22.22% | 7.78% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more